2025 PRESENTER PROFILES
Use of Diabetes Technology in Outpatient Pregnancy Management
Monday, June 23, at 8:00 a.m. CT
Room W181 A-C • McCormick Place Convention Center
Automated Insulin Delivery Systems in Pregnancy—Working with Systems to Optimize Outcomes
Emily Szmuilowicz, MD, MS
Associate Professor of Medicine,
Northwestern University
What is your presentation about?
While automated insulin delivery (AID) is the preferred method of insulin delivery for non-pregnant individuals with type 1 diabetes, none of the AID systems commercially available in North America are approved for use during pregnancy, and these systems are not ideally designed for use in pregnancy. However, many pregnant individuals use and benefit from AID, and AID has emerged as a key treatment modality in the face of the significant challenges encountered in achieving glycemic targets during pregnancy. Therefore, strategies for optimization of AID use during pregnancy are greatly needed in clinical practice.
How do you hope your presentation will impact diabetes research or care?
Practical strategies to optimize AID use during pregnancy are needed. In this presentation, we will highlight common challenges encountered with AID use during pregnancy and, importantly, best-practice workarounds.
How did you become involved with this area of diabetes research or care?
In my clinical work caring for pregnant individuals with diabetes and serving as the endocrine director of our multidisciplinary diabetes in pregnancy program, I see firsthand both the challenges faced in achieving glycemic targets in pregnancy as well as the benefits which many individuals derive from AID use. I am enthusiastic to share practical strategies to support individualized care for pregnant individuals with diabetes.
